CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 104 filers reported holding CULLINAN ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,081,373 | +4.1% | 229,986 | +23.8% | 0.00% | 0.0% |
| Q2 2023 | $1,999,057 | +4.2% | 185,786 | -0.9% | 0.00% | 0.0% |
| Q1 2023 | $1,918,463 | -17.6% | 187,533 | -15.0% | 0.00% | 0.0% |
| Q4 2022 | $2,326,971 | -16.6% | 220,566 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $2,789,000 | +17.1% | 217,538 | +17.1% | 0.00% | 0.0% |
| Q2 2022 | $2,382,000 | +27.7% | 185,773 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $1,866,000 | -30.6% | 178,150 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $2,689,000 | -30.2% | 174,213 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $3,854,000 | +66.8% | 170,744 | +90.4% | 0.00% | 0.0% |
| Q2 2021 | $2,310,000 | -35.9% | 89,699 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $3,602,000 | – | 86,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |